Review
doi: 10.1038/nrm1983.Regulation of cardiac hypertrophy by intracellular signalling pathways
Affiliations
- PMID:16936699
- DOI: 10.1038/nrm1983
Item in Clipboard
Review
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al. Nat Rev Mol Cell Biol.2006 Aug.
Display options
Format
Display options
Format
Abstract
The mammalian heart is a dynamic organ that can grow and change to accommodate alterations in its workload. During development and in response to physiological stimuli or pathological insults, the heart undergoes hypertrophic enlargement, which is characterized by an increase in the size of individual cardiac myocytes. Recent findings in genetically modified animal models implicate important intermediate signal-transduction pathways in the coordination of heart growth following physiological and pathological stimulation.
Similar articles
- Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.Molkentin JD.Molkentin JD.Cardiovasc Res. 2004 Aug 15;63(3):467-75. doi: 10.1016/j.cardiores.2004.01.021.Cardiovasc Res. 2004.PMID:15276472Review.
- Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses.Clerk A, Cullingford TE, Fuller SJ, Giraldo A, Markou T, Pikkarainen S, Sugden PH.Clerk A, et al.J Cell Physiol. 2007 Aug;212(2):311-22. doi: 10.1002/jcp.21094.J Cell Physiol. 2007.PMID:17450511Review.
- Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.Shiojima I, Walsh K.Shiojima I, et al.Genes Dev. 2006 Dec 15;20(24):3347-65. doi: 10.1101/gad.1492806.Genes Dev. 2006.PMID:17182864Review.
- Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats.Kuo WW, Chung LC, Liu CT, Wu SP, Kuo CH, Tsai FJ, Tsai CH, Lu MC, Huang CY, Lee SD.Kuo WW, et al.Cell Biochem Funct. 2009 Oct;27(7):479-87. doi: 10.1002/cbf.1601.Cell Biochem Funct. 2009.PMID:19718675
- STRESS signaling pathways that modulate cardiac myocyte apoptosis.Baines CP, Molkentin JD.Baines CP, et al.J Mol Cell Cardiol. 2005 Jan;38(1):47-62. doi: 10.1016/j.yjmcc.2004.11.004. Epub 2004 Dec 9.J Mol Cell Cardiol. 2005.PMID:15623421Review.
Cited by
- Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.Huang Q, Zhou HJ, Zhang H, Huang Y, Hinojosa-Kirschenbaum F, Fan P, Yao L, Belardinelli L, Tellides G, Giordano FJ, Budas GR, Min W.Huang Q, et al.Circulation. 2015 Mar 24;131(12):1082-97. doi: 10.1161/CIRCULATIONAHA.114.012725. Epub 2015 Jan 27.Circulation. 2015.PMID:25628390Free PMC article.
- Systems biology approaches for advancing the discovery of effective drug combinations.Ryall KA, Tan AC.Ryall KA, et al.J Cheminform. 2015 Feb 26;7:7. doi: 10.1186/s13321-015-0055-9. eCollection 2015.J Cheminform. 2015.PMID:25741385Free PMC article.
- Protein quality control and metabolism: bidirectional control in the heart.Wang ZV, Hill JA.Wang ZV, et al.Cell Metab. 2015 Feb 3;21(2):215-226. doi: 10.1016/j.cmet.2015.01.016.Cell Metab. 2015.PMID:25651176Free PMC article.Review.
- In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy.Seymour AM, Giles L, Ball V, Miller JJ, Clarke K, Carr CA, Tyler DJ.Seymour AM, et al.Cardiovasc Res. 2015 May 1;106(2):249-60. doi: 10.1093/cvr/cvv101. Epub 2015 Mar 5.Cardiovasc Res. 2015.PMID:25750189Free PMC article.
- Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.Xu T, Tang H, Zhang B, Cai C, Liu X, Han Q, Zou L.Xu T, et al.Int J Clin Exp Pathol. 2015 Jan 1;8(1):530-40. eCollection 2015.Int J Clin Exp Pathol. 2015.PMID:25755743Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources